Identification and treatment of individuals with attention-deficit/hyperactivity disorder and substance use disorder: An expert consensus statement

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 3

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Psychiatry

ISSN

2220-3206

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Expert Consensus

World J Psychiatry. Mar 19, 2023; 13(3): 84-112
Published online Mar 19, 2023. doi: 10.5498/wjp.v13.i3.84

Table 5 Overlapping symptoms between attention-deficit/hyperactivity disorder, substance use/substance use disorder and other psychiatric disorders

Symptom	ADHD	SU/SUD	Other psychiatric comorbidity¹
Agitation	√	√	√
Anxiety	√	√	√
Hyperactivity	√		√
Impulsivity	√	√	√
Inattention	√	√	√
Intolerance to frustrations	√	√	√
Mood instability	√	√	√
Poor concentration	√	√	√
Poor memory	√	√	√
Restlessness	√	√	√
Risk-taking behavior	√	√	√
Sleep difficulties	√		√

¹Anxiety, depression, bipolar disorder, personality disorders.

ADHD: Attention-deficit/hyperactivity disorder; SU: Substance use; SUD: Substance use disorder.

Citation: Young S, Abbasian C, Al-Attar Z, Branney P, Colley B, Cortese S, Cubbin S, Deeley Q, Gudjonsson GH, Hill P, Hollingdale J, Jenden S, Johnson J, Judge D, Lewis A, Mason P, Mukherjee R, Nutt D, Roberts J, Robinson F, Woodhouse E, Cocallis K. Identification and treatment of individuals with attention-deficit/hyperactivity disorder and substance use disorder: An expert consensus statement. World J Psychiatry 2023; 13(3): 84-112
URL: https://www.wjgnet.com/2220-3206/full/v13/i3/84.htm
DOI: https://dx.doi.org/10.5498/wjp.v13.i3.84

Young S, Abbasian C, Al-Attar Z, Branney P, Colley B, Cortese S, Cubbin S, Deeley Q, Gudjonsson GH, Hill P, Hollingdale J, Jenden S, Johnson J, Judge D, Lewis A, Mason P, Mukherjee R, Nutt D, Roberts J, Robinson F, Woodhouse E, Cocallis K. Identification and treatment of individuals with attention-deficit/hyperactivity disorder and substance use disorder: An expert consensus statement. World J Psychiatry 2023; 13(3): 84-112 [PMID: 37033892 DOI: 10.5498/wjp.v13.i3.84]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.